Form 4: Silence Therapeutics Insider Reports Stock Transaction
Insider Transaction (Form 4)
Richard Ian Griffiths, a 10% owner of Silence Therapeutics plc, reported multiple transactions in common stock on August 10, 2026.
Summary
- Open-market sale: acquired 2,792,826 American Depositary Shares on August 10, 2026; holds 7,488,660 after (Indirect).
- Open-market sale: acquired 100,000 American Depositary Shares on August 10, 2026; holds 7,388,660 after (Indirect).
- Open-market sale: acquired 50,000 American Depositary Shares on August 10, 2026; holds 7,338,660 after (Indirect).
- Open-market sale: acquired 3,500 American Depositary Shares on August 10, 2026; holds 7,335,160 after (Indirect).
- Open-market sale: acquired 800,000 American Depositary Shares on August 10, 2026; holds 6,535,160 after (Indirect).
- Open-market sale: acquired 382,000 American Depositary Shares on August 10, 2026; holds 6,153,160 after (Indirect).
- Open-market sale: acquired 470,820 American Depositary Shares on August 10, 2026; holds 5,682,340 after (Indirect).
- Open-market sale: acquired 605,174 American Depositary Shares on August 10, 2026; holds 5,077,166 after (Indirect).
- Open-market sale: acquired 120,000 American Depositary Shares on August 10, 2026; holds 4,957,166 after (Indirect).
- Open-market sale: acquired 60,000 American Depositary Shares on August 10, 2026; holds 4,897,166 after (Indirect).
- Open-market sale: acquired 100,000 American Depositary Shares on August 10, 2026; holds 4,797,166 after (Indirect).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Richard Ian Griffiths — 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-10 | Open-market sale | American Depositary Shares | 2,792,826 | — | — | 7,488,660 |
| 2026-08-10 | Open-market sale | American Depositary Shares | 100,000 | — | — | 7,388,660 |
| 2026-08-10 | Open-market sale | American Depositary Shares | 50,000 | — | — | 7,338,660 |
| 2026-08-10 | Open-market sale | American Depositary Shares | 3,500 | — | — | 7,335,160 |
| 2026-08-10 | Open-market sale | American Depositary Shares | 800,000 | — | — | 6,535,160 |
| 2026-08-10 | Open-market sale | American Depositary Shares | 382,000 | — | — | 6,153,160 |
| 2026-08-10 | Open-market sale | American Depositary Shares | 470,820 | — | — | 5,682,340 |
| 2026-08-10 | Open-market sale | American Depositary Shares | 605,174 | — | — | 5,077,166 |
| 2026-08-10 | Open-market sale | American Depositary Shares | 120,000 | — | — | 4,957,166 |
| 2026-08-10 | Open-market sale | American Depositary Shares | 60,000 | — | — | 4,897,166 |
| 2026-08-10 | Open-market sale | American Depositary Shares | 100,000 | — | — | 4,797,166 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-10 | Open-market sale (2,792,826 shares) |
| 2026-08-10 | Open-market sale (100,000 shares) |
| 2026-08-10 | Open-market sale (50,000 shares) |
| 2026-08-10 | Open-market sale (3,500 shares) |
| 2026-08-10 | Open-market sale (800,000 shares) |
| 2026-08-10 | Open-market sale (382,000 shares) |
| 2026-08-10 | Open-market sale (470,820 shares) |
| 2026-08-10 | Open-market sale (605,174 shares) |
| 2026-08-10 | Open-market sale (120,000 shares) |
| 2026-08-10 | Open-market sale (60,000 shares) |
| 2026-08-10 | Open-market sale (100,000 shares) |
Keywords
insider transaction, Form 4, SLN, Silence Therapeutics plc, neutral, Richard Ian Griffiths
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.